Table 1.
Rate of HIV pol sequences PCR amplification from plasma and DPS paired samples.
| ID | Time of DPS storage (days) |
VL∗ (log10 copies/mL) | PCR amplification | DR genotype∗∗ | |||
|---|---|---|---|---|---|---|---|
| Plasma | DPS | Plasma | DPS | Plasma | DPS | ||
| HIV-47 | 3 | 6.2 | 6.1 | + | + | + | + |
| HIV-03 | 7 | 6.1 | 4.6 | + | + | + | + |
| HIV-43 | 7 | 5.4 | 4.8 | + | + | + | + |
| HIV-08 | 7 | 5.3 | 4.7 | + | + | + | + |
| HIV-86 | 7 | 5.2 | 4.5 | + | + | + | + |
| HIV-31 | 7 | 5.1 | 4.9 | + | + | + | + |
| HIV-55 | 7 | 5.0 | 4.7 | − | + | + | − |
| HIV-64 | 7 | 5.0 | 4.4 | + | + | + | + |
| HIV-88 | 12 | 5.0 | 4.4 | + | − | − | + |
| HIV-20 | 7 | 5.0 | 4.5 | + | + | + | + |
| HIV-13 | 12 | 4.9 | 4.9 | + | + | + | + |
| HIV-18 | 7 | 4.8 | 4.0 | + | + | + | + |
| HIV-54 | 7 | 4.7 | 3.8 | − | − | − | − |
| HIV-89 | 7 | 4.5 | 3.6 | + | + | + | − |
| HIV-66 | 7 | 4.3 | 3.5 | − | − | − | − |
| HIV-69 | 7 | 4.3 | 3.7 | − | − | − | − |
| HIV-62 | 7 | 4.3 | 3.5 | − | − | − | − |
| HIV-39 | 7 | 4.2 | 3.5 | − | − | − | − |
| HIV-04 | 7 | 4.9 | 4.0 | + | + | + | + |
| HIV-02 | 7 | 3.5 | 3.1 | − | − | − | − |
| HIV-01 | 7 | 2.1 | 1.7 | − | − | − | − |
| HIV-22¹ | 910 | 4.4 | 4.5 | + | + | + | + |
|
| |||||||
| Average ± SD | 4.8 ± 0.9 | 4.2 ± 0.9 | 14/22 | 14/22 | 14/22 | 13/22 | |
|
| |||||||
| Rate of PCR amplification and genotyping (%) | 63.6 | 59.1 | |||||
∗VL in DPS and liquid plasma using Amplicor HIV-1 Monitor Test, version 1.5.
∗∗Stanford genotyping drug resistance interpretation algorithm (v.4.2.6) (http://sierra2.stanford.edu/sierra/servlet/JSierra). DR: drug resistance genotype.
¹HIV-DPS sample stored for 910 days.